Research & Innovation
From Evidence to Everyday Practice
Creating space where academia, industry, and frontline clinicians can advance CKM science together.
Focus Areas
Where We Invest Attention
Shared Pathophysiology
Understanding the biology linking cardiac, renal, and metabolic dysfunction across the lifespan.
Risk Prediction & Staging
Improving early identification of CKM risk with validated tools and real-world data.
Digital Health & AI
Evaluating decision support, remote monitoring, and analytics that scale prevention.
Therapeutic Innovation
Tracking emerging cardiometabolic and renal therapies and their integration into practice.
Implementation Science
Translating guidelines into workflows that clinics and health systems can actually sustain.
Health Equity Research
Addressing disparities in CKM detection, treatment access, and long-term outcomes.
Innovation Exchange
Collaborate on CKM Science
Investigators, innovators, and industry partners are invited to propose collaborations during the founding phase.
Research Agenda
Questions the Field Needs Answered
Priority questions identified with our founding scientific network.
- Which CKM staging thresholds best predict events in diverse populations?
- How do we increase albuminuria testing rates at scale in primary care?
- What sequence and combination of cross-axis therapies delivers the most benefit per cost?
- How can risk estimation be adapted for settings without routine laboratory access?
- What team structures produce durable improvement in CKM outcomes?
- Which digital tools genuinely improve adherence rather than adding clinician burden?
- How do social drivers modify treatment effect across the CKM stages?
- What patient-reported outcomes matter most to people living with CKM syndrome?
Programs
Research Programs in Development
Structures the Society is building to support investigators at every career stage.
- Early-career CKM research awards and travel grants for summit presenters
- Abstract submission and peer review for Society scientific sessions
- A collaborative implementation registry documenting real-world CKM pathways
- Methods workshops on risk modeling, competing risks, and pragmatic trial design
- Mentor matching between senior investigators and trainees across specialties
- Position statements and consensus documents authored by working groups
Integrity
Scientific Standards
All Society-affiliated research activity follows disclosure, authorship, and data-sharing standards consistent with international recommendations for medical journals. Investigators declare funding and relevant relationships; industry support does not confer authorship or control over analysis or interpretation.
Where the Society hosts or co-hosts a registry or collaborative dataset, participation requires appropriate ethics approval, informed consent where applicable, and a written data use agreement. Aggregate findings are published regardless of direction of result.